CODEXIS, INC. (CDXS)

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Address

200 PENOBSCOT DRIVE

REDWOOD CITY, CA 94063

Founded

2002

Number of Employees

174

Website

http://www.codexis.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s)	-	-	$399	-	-	-	-	-	-	-	-	$399
Average Price	-	-	$4.08	-	-	-	-	-	-	-	-	$4.08
# Shares Purchased	-	-	97,838	-	-	-	-	-	-	-	-	97,838

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-	-	-51.0%	-	-	-	-	-	-	-	-	-51.0%
S&P 500 Return to Date	-	-	168.6%	-	-	-	-	-	-	-	-	168.6%
Excess Total Return	-	-	-219.6%	-	-	-	-	-	-	-	-	-219.6%
Quartile Rank
Percentile Rank	-	-	15%	-	-	-	-	-	-	-	-	13%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed

CareDx, Inc.

NICOLS JOHN J

CODEXIS, INC.

EQUILON ENTERPRISES LLC